These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 25864591)
1. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition. Zhu LY; Zhang WM; Yang XM; Cui L; Li J; Zhang YL; Wang YH; Ao JP; Ma MZ; Lu H; Ren Y; Xu SH; Yang GD; Song WW; Wang JH; Zhang XD; Zhang R; Zhang ZG Cancer Lett; 2015 Jul; 363(1):71-82. PubMed ID: 25864591 [TBL] [Abstract][Full Text] [Related]
2. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway. Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697 [TBL] [Abstract][Full Text] [Related]
3. MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1. Zhang LY; Chen Y; Jia J; Zhu X; He Y; Wu LM Cancer Biomark; 2019; 24(1):31-42. PubMed ID: 30614794 [TBL] [Abstract][Full Text] [Related]
4. Silencing of LRRFIP1 reverses the epithelial-mesenchymal transition via inhibition of the Wnt/β-catenin signaling pathway. Douchi D; Ohtsuka H; Ariake K; Masuda K; Kawasaki S; Kawaguchi K; Fukase K; Oikawa M; Motoi F; Naitoh T; Katayose Y; Egawa S; Unno M Cancer Lett; 2015 Aug; 365(1):132-40. PubMed ID: 26047573 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Zhang Y; Dun Y; Zhou S; Huang XH Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819 [TBL] [Abstract][Full Text] [Related]
6. PCNP promotes ovarian cancer progression by accelerating β-catenin nuclear accumulation and triggering EMT transition. Dong P; Fu H; Chen L; Zhang S; Zhang X; Li H; Wu D; Ji X J Cell Mol Med; 2020 Jul; 24(14):8221-8235. PubMed ID: 32548978 [TBL] [Abstract][Full Text] [Related]
7. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer. Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316 [TBL] [Abstract][Full Text] [Related]
8. MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration. Min P; Zhao S; Liu L; Zhang Y; Ma Y; Zhao X; Wang Y; Song Y; Zhu C; Jiang H; Gu L; Du J J Cell Mol Med; 2019 Jun; 23(6):4475-4488. PubMed ID: 31034158 [TBL] [Abstract][Full Text] [Related]
9. Silencing of Prrx2 Inhibits the Invasion and Metastasis of Breast Cancer both In Vitro and In Vivo by Reversing Epithelial-Mesenchymal Transition. Lv ZD; Wang HB; Liu XP; Jin LY; Shen RW; Wang XG; Kong B; Qu HL; Li FN; Yang QF Cell Physiol Biochem; 2017; 42(5):1847-1856. PubMed ID: 28750408 [TBL] [Abstract][Full Text] [Related]
10. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer. Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234 [TBL] [Abstract][Full Text] [Related]
11. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT. Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294 [TBL] [Abstract][Full Text] [Related]
12. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672 [TBL] [Abstract][Full Text] [Related]
13. Annexin A2 inhibition suppresses ovarian cancer progression via regulating β-catenin/EMT. Liu Y; Li H; Ban Z; Nai M; Yang L; Chen Y; Xu Y Oncol Rep; 2017 Jun; 37(6):3643-3650. PubMed ID: 28440436 [TBL] [Abstract][Full Text] [Related]
14. LY75 Ablation Mediates Mesenchymal-Epithelial Transition (MET) in Epithelial Ovarian Cancer (EOC) Cells Associated with DNA Methylation Alterations and Suppression of the Wnt/β-Catenin Pathway. Mehdi S; Bachvarova M; Scott-Boyer MP; Droit A; Bachvarov D Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32156068 [TBL] [Abstract][Full Text] [Related]
15. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
16. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer. Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341 [TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 promotes epithelial-to-mesenchymal transition in human ovarian cancer cells. Rosanò L; Spinella F; Di Castro V; Nicotra MR; Dedhar S; de Herreros AG; Natali PG; Bagnato A Cancer Res; 2005 Dec; 65(24):11649-57. PubMed ID: 16357176 [TBL] [Abstract][Full Text] [Related]
18. Involvement of actinin-4 in the recruitment of JRAB/MICAL-L2 to cell-cell junctions and the formation of functional tight junctions. Nakatsuji H; Nishimura N; Yamamura R; Kanayama HO; Sasaki T Mol Cell Biol; 2008 May; 28(10):3324-35. PubMed ID: 18332111 [TBL] [Abstract][Full Text] [Related]
19. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Duan H; Yan Z; Chen W; Wu Y; Han J; Guo H; Qiao J Gynecol Oncol; 2017 Nov; 147(2):408-417. PubMed ID: 28851501 [TBL] [Abstract][Full Text] [Related]
20. CCAAT enhancer binding protein α suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling. Zhang LM; Li M; Tian CC; Wang TT; Mi SF Neoplasma; 2021 May; 68(3):602-612. PubMed ID: 33780265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]